Browsing by Author FerroKin BioSciences, Inc.
Showing results 1 to 2 of 2
|1-Apr-2011||A phase 1 dose-escalation study: Safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload||Hugh Young Rienhoff; Vip Viprakasit; Lay Tay; Paul Harmatz; Elliott Vichinsky; Deborah Chirnomas; Janet L. Kwiatkowski; Amy Tapper; William Kramer; John B. Porter; Ellis J. Neufeld; FerroKin BioSciences, Inc.; Mahidol University; Institute of Medical and Veterinary Science Australia; UCSF Benioff Children's Hospital Oakland; Children's Hospital Boston; The Children's Hospital of Philadelphia; UCL|
|5-Apr-2012||A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload||Ellis J. Neufeld; Renzo Galanello; Vip Viprakasit; Yesim Aydinok; Antonio Piga; Paul Harmatz; Gian Luca Forni; Farrukh T. Shah; Rachael F. Grace; John B. Porter; John C. Wood; Jennifer Peppe; Amber Jones; Hugh Young Rienhoff; Harvard University; Universita degli Studi di Cagliari; Mahidol University; Ege University Medical School; Scienze Cliniche e Biologiche; UCSF Benioff Children's Hospital Oakland; E.O. Ospedali Galliera; Whittington Hospital; UCL; Children's Hospital Los Angeles; FerroKin BioSciences, Inc.|